Skip to main content
. 2010 Apr 7;15(4):970–982. doi: 10.1111/j.1582-4934.2010.01065.x

Fig 9.

Fig 9

Effect of ERK1/2 inhibitor PD-98059 on Elk-1 activity. ERK1/2 inhibitor PD-98059 (100 μM) prevented the IL-1β-induced activation of Elk-1 as assessed by ELISA-binding assay (means ± S.E., n= 5). *P < 0.0001 versus control; **P < 0.001 versus IL-1β treatment.